Pelvic adaptive radiotherapy study
Part of Cancer clinical trials.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are able to get around and care for yourself (ECOG score 0-2)
- You have one of these cancers that needs radiation to the pelvis: prostate (with lymph nodes needed or after surgery), bladder, rectal, anal, or a gynecologic cancer after surgery, or you only need radiation to the pelvic lymph nodes
- You do not have a hip replacement (hip prosthesis)
- The distance from the center of the radiation area to your skin must be less than 24 cm, as measured on a scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of radiation therapy for prostate cancer that adjusts to small changes in your body. It aims to better target the cancer while reducing side effects.
This trial tests a personalized radiation therapy approach for gynecological tumors. It aims to improve treatment by adapting the radiation plan based on changes in the tumor and nearby organs during your therapy course.
This trial compares two ways of giving radiation to the prostate and pelvic lymph nodes. It also tests two different instructions for how full your bladder should be during treatment. The goal is to see which approach works better and is easier for patients.
This Phase 1 study tests an “adaptive” form of focused radiation (SBRT) for cancers that have spread in the abdomen or pelvis. It aims to treat metastatic tumor spots safely while adjusting the plan as needed during treatment.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
This study collects data from patients receiving a type of radiation therapy that is adjusted in real-time. It aims to learn more about how well this approach works for pelvic and chest tumors.
Hear when a new Pelvis Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.